CPC A61F 2/16 (2013.01) [A61F 2002/169 (2015.04); A61F 2002/16901 (2015.04); A61F 2002/16902 (2015.04); A61F 2220/0025 (2013.01); A61F 2250/0068 (2013.01)] | 10 Claims |
1. An intraocular drug delivery platform for use with an intraocular lens (IOL), comprising:
a flat ring comprising an anterior surface, a posterior surface opposite the anterior surface, and a central aperture formed by the ring,
a first haptic coupled to and extending outwards from the ring,
a second haptic coupled to and extending outwards from the ring,
a first drug eluting mass comprising a therapeutic agent coupled to the anterior surface of the ring,
a second drug eluting mass comprising the therapeutic agent coupled to the anterior surface of the ring and positioned directly opposite of the first drug eluting mass,
a skirt extending posteriorly from the posterior surface of the ring and partially or fully circumscribing the central aperture, and
an intraocular lens (IOL) configured to be retained in a position by the intraocular drug delivery platform, the OIL comprising a first lens haptic and a second lens haptic,
wherein the skirt comprises an inner diameter sized and configured to retain the OIL within the skirt.
|